The Peptide Paradox: Balancing Promises of Longevity with Regulatory Realities The pharmaceutical industry is abuzz with the promise of peptide therapies, which are being touted as elixirs for a longer, healthier life.
However, behind the glossy marketing and online sales lies a more nuanced reality: regulatory limbo. Compounding pharmacies are now clamoring to make these products legally available, citing consumer demand.
Peptide therapies have proliferated largely unmonitored by health regulators, who seem caught off guard by their rapid rise in popularity.